The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60.
Cheniere Energy Partners LP
CQP · the NYSE · USD · Market cap $29.9B
Cheniere Energy Partners, L.P., through its subsidiaries, provides liquefied natural gas (LNG) to integrated energy companies, utilities, and energy trading companies in the United States and internationally.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 10:20 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price61.81 USD at the 13 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.26)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $45.90 to $60.01, base estimate $52.18 (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.26, read 2026-11-15
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Cheniere Energy Partners LP holds its Distribution at $61.81. Consolidating, no directional conviction, held for 2 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price at the screen | $61.81 |
| Valuation | 10.81 trailing · 11.75 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.28 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 82.97% | Below 33% | Interest-bearing debt is 83.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 5.12% | Below 49% | Money owed to the company is 5.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.17% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Cheniere Energy Partners LP's business is in a permissible area, but its interest-bearing debt is about 83% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CQP's ethical verdict changes
Today CQP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $52.18 fair value estimate, narrow competitive moat, 7.10% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 18.5% above the base estimate.
Third-party analyst targets: 13 covering, consensus Underperform. The average target sits −3% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $52.18, with a range of $45.90 to $60.01, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 11.7x forward earnings, the price already runs ahead of the business. It trades 18% above our $52.18 fair value, so you would be buying at a premium, not a discount. The narrow moat is real, but quality alone does not make an expensive price cheap.
| Forward P/E | 11.7xpriced for continued growth |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 5.72 |
| EPS, forward | 5.26 |
| Revenue growth | +7.1%slow but positive growth |
| Profit margin | 28.1%healthy profit margins |
| Return on equity | 1,232.8%an exceptional return on shareholder capital |
| FCF yield | 7.67% |
| Dividend yield | 5.63% |
| Debt to equity | 16.39heavy leverage: higher risk if revenue softens |
| Current ratio | 1.19adequate liquidity, worth monitoring |
| Beta | 0.28barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 51.47 - 71.25 |
| Moat | NARROW |
| Market cap | $29.9B |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCQP trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 14.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it underperform, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- How Investors Are Reacting To Cheniere Energy Partners (CQP) Tightened Distribution Guidance Yahoo Finance · 10d ago
- Cheniere Partners Reports Third Quarter 2026 Results and Tightens Full Year 2026 Distribution Guidance Yahoo Finance · 18d ago
- Cheniere Energy Boosts LNG Contract Backlog With QatarEnergy Deal Yahoo Finance · 24d ago
- Cheniere Partners Declares Quarterly Distributions Yahoo Finance · 24d ago
- Cheniere signs LNG supply deals with QatarEnergy through 2054 Yahoo Finance · 24d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $61.84 | +8.5% | · | $1,085 | +8.5% |
| 2 months | $62.16 | +7.9% | $0.79 | $1,092 | +9.2% |
| 3 months | $63.10 | +6.3% | $0.79 | $1,076 | +7.6% |
| 6 months | $52.51 | +27.8% | $1.62 | $1,308 | +30.8% |
| 1 year | $53.71 | +24.9% | $3.27 | $1,310 | +31.0% |
| 2 years | $43.56 | +54.0% | $6.53 | $1,690 | +69.0% |
| 3 years | $36.49 | +83.9% | $10.44 | $2,124 | +112.4% |
| 5 years | $30.73 | +118.3% | $17.76 | $2,760 | +176.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CQP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.